NCT05009368已完成1 期
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Phase 1 Study to Evaluate the Pharmacokinetic Interaction and Safety of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- Celltrion
- 入组人数
- 41
- 试验地点
- 2
- 主要终点
- AUCτ,ss
研究概览
简要总结
This is a two-arm, open-label, single-sequence, multiple-dose, cross-over phase 1 study to evaluate the interaction between two investigational drugs by comparing and analyzing the pharmacokinetic interaction and safety of CTL0901 and CTL0902 at steady state when administered alone or in combination with repeated oral doses in healthy adult volunteers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •A subject who weighs 50 kg or more (45 kg or more for women)
- •A subject who does not have clinically significant congenital or chronic diseases
- •A subject who is judged to be eligible to participate by the results of diagnostic tests by the principal investigator
- •A subject and their partner who agree to use a medically appropriate method of contraception to exclude potential of pregnancy and not to provide sperm or ova from the first dose to 7 days after the last dose of the investigational drug
- •A subject who voluntarily signs the consent form after hearing and understanding the purpose and content of this study, the characteristics of the investigational drugs, and expected adverse reactions
排除标准
- •A subject who has a known digestive system, cardiovascular system, endocrine system, respiratory system, blood·tumor, infectious disease, kidney and genitourinary system, mental·nervous system, musculoskeletal system, immune system, otolaryngology, skin system, ophthalmic system or has any past history of them
- •A subject who has a history of gastrointestinal surgery that may affect drug absorption (except simple appendectomy or hernia surgery) or has gastrointestinal diseases
- •A subject who has taken drugs that induce or inhibit drug metabolizing enzymes such as barbiturates within 1 month of the first administration or has taken drugs that may affect the study within 10 days of the first administration (however, participation can be possible considering pharmacokinetic·pharmacodynamic characteristics such as interaction with concomitant drugs and half-life of concomitant drugs etc)
- •A subject who has participated and administered other investigational drugs in other clinical trials or bioequivalence studies within 6 months of the first administration
- •A subject who is judged ineligible for participation in this study by the principal investigator
- •A female volunteer who is pregnant or lactating
结局指标
主要结局
AUCτ,ss
时间窗: predose(0 hour), 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 2.5, 3, 4, 6, 8, 12 and, 24 hours postdose
Cmax,ss
时间窗: predose(0 hour), 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 2.5, 3, 4, 6, 8, 12 and, 24 hours postdose
次要结局
- Tmax,ss(predose(0 hour), 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 2.5, 3, 4, 6, 8, 12 and, 24 hours postdose)
- Cmin,ss(predose(0 hour), 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 2.5, 3, 4, 6, 8, 12 and, 24 hours postdose)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult VolunteersHealth, SubjectiveNCT05002244Celltrion37
招募中
1 期
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsOncologyMEK MutationRAF Gene MutationRas (KRAS or NRAS) Gene MutationSolid Tumor, AdultMAPK Pathway Gene MutationMelanomaGliomaNSCLCNCT06326411Nested Therapeutics, Inc230
已完成
1 期
Bioavailability of Levoketoconazole and Ketoconazole TabletsHealthyNCT04212000Cortendo AB34
已完成
1 期
Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy SubjectsHealthyNCT02609139Pfizer18
Unknown
1 期
Effect of Food on Pharmacokinetics of Salvianolic Acid A in Healthy SubjectsHealthyNCT03791463Peking University First Hospital14